Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
Identifieur interne : 002B54 ( PubMed/Corpus ); précédent : 002B53; suivant : 002B55Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
Auteurs : Hyun Chul Song ; Mi-Young Seo ; Konrad Stadler ; Byoung J. Yoo ; Qui-Lim Choo ; Stephen R. Coates ; Yasushi Uematsu ; Takashi Harada ; Catherine E. Greer ; John M. Polo ; Piero Pileri ; Markus Eickmann ; Rino Rappuoli ; Sergio Abrignani ; Michael Houghton ; Jang H. HanSource :
- Journal of virology [ 0022-538X ] ; 2004.
English descriptors
- KwdEn :
- Animals, Antigens, Viral (chemistry), Antigens, Viral (genetics), Antigens, Viral (immunology), Antigens, Viral (metabolism), COS Cells, Cell Line, Chlorocebus aethiops, Cricetinae, Culture Media (chemistry), DNA, Complementary, DNA, Viral (genetics), DNA, Viral (metabolism), Endoplasmic Reticulum (chemistry), Glycoside Hydrolases (metabolism), Golgi Apparatus (chemistry), Membrane Glycoproteins (chemistry), Membrane Glycoproteins (genetics), Membrane Glycoproteins (immunology), Membrane Glycoproteins (metabolism), Molecular Weight, Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase (metabolism), Protein Folding, Protein Processing, Post-Translational, Protein Structure, Tertiary, Protein Subunits (analysis), Protein Transport, Recombinant Proteins (chemistry), Recombinant Proteins (genetics), Recombinant Proteins (immunology), Recombinant Proteins (metabolism), SARS Virus (genetics), Spike Glycoprotein, Coronavirus, Viral Envelope Proteins (chemistry), Viral Envelope Proteins (genetics), Viral Envelope Proteins (immunology), Viral Envelope Proteins (metabolism).
- MESH :
- chemical , analysis : Protein Subunits.
- chemical , chemistry : Antigens, Viral, Culture Media, Membrane Glycoproteins, Recombinant Proteins, Viral Envelope Proteins.
- chemical , genetics : Antigens, Viral, DNA, Viral, Membrane Glycoproteins, Recombinant Proteins, Viral Envelope Proteins.
- chemical , immunology : Antigens, Viral, Membrane Glycoproteins, Recombinant Proteins, Viral Envelope Proteins.
- chemical , metabolism : Antigens, Viral, DNA, Viral, Glycoside Hydrolases, Membrane Glycoproteins, Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase, Recombinant Proteins, Viral Envelope Proteins.
- chemistry : Endoplasmic Reticulum, Golgi Apparatus.
- genetics : SARS Virus.
- Animals, COS Cells, Cell Line, Chlorocebus aethiops, Cricetinae, DNA, Complementary, Molecular Weight, Protein Folding, Protein Processing, Post-Translational, Protein Structure, Tertiary, Protein Transport, Spike Glycoprotein, Coronavirus.
Abstract
We have expressed and characterized the severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein in cDNA-transfected mammalian cells. The full-length spike protein (S) was newly synthesized as an endoglycosidase H (endo H)-sensitive glycoprotein (gp170) that is further modified into an endo H-resistant glycoprotein (gp180) in the Golgi apparatus. No substantial proteolytic cleavage of S was observed, suggesting that S is not processed into head (S1) and stalk (S2) domains as observed for certain other coronaviruses. While the expressed full-length S glycoprotein was exclusively cell associated, a truncation of S by excluding the C-terminal transmembrane and cytoplasmic tail domains resulted in the expression of an endoplasmic reticulum-localized glycoprotein (gp160) as well as a Golgi-specific form (gp170) which was ultimately secreted into the cell culture medium. Chemical cross-linking, thermal denaturation, and size fractionation analyses suggested that the full-length S glycoprotein of SARS-CoV forms a higher order structure of approximately 500 kDa, which is consistent with it being an S homotrimer. The latter was also observed in purified virions. The intracellular form of the C-terminally truncated S protein (but not the secreted form) also forms trimers, but with much less efficiency than full-length S. Deglycosylation of the full-length homotrimer with peptide N-glycosidase-F under native conditions abolished recognition of the protein by virus-neutralizing antisera raised against purified virions, suggesting the importance of the carbohydrate in the correct folding of the S protein. These data should aid in the design of recombinant vaccine antigens to prevent the spread of this emerging pathogen.
DOI: 10.1128/JVI.78.19.10328-10335.2004
PubMed: 15367599
Links to Exploration step
pubmed:15367599Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.</title>
<author><name sortKey="Song, Hyun Chul" sort="Song, Hyun Chul" uniqKey="Song H" first="Hyun Chul" last="Song">Hyun Chul Song</name>
<affiliation><nlm:affiliation>Vaccines Research, Chiron Corporation, 4560 Horton St., Emeryville, CA 94608, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Seo, Mi Young" sort="Seo, Mi Young" uniqKey="Seo M" first="Mi-Young" last="Seo">Mi-Young Seo</name>
</author>
<author><name sortKey="Stadler, Konrad" sort="Stadler, Konrad" uniqKey="Stadler K" first="Konrad" last="Stadler">Konrad Stadler</name>
</author>
<author><name sortKey="Yoo, Byoung J" sort="Yoo, Byoung J" uniqKey="Yoo B" first="Byoung J" last="Yoo">Byoung J. Yoo</name>
</author>
<author><name sortKey="Choo, Qui Lim" sort="Choo, Qui Lim" uniqKey="Choo Q" first="Qui-Lim" last="Choo">Qui-Lim Choo</name>
</author>
<author><name sortKey="Coates, Stephen R" sort="Coates, Stephen R" uniqKey="Coates S" first="Stephen R" last="Coates">Stephen R. Coates</name>
</author>
<author><name sortKey="Uematsu, Yasushi" sort="Uematsu, Yasushi" uniqKey="Uematsu Y" first="Yasushi" last="Uematsu">Yasushi Uematsu</name>
</author>
<author><name sortKey="Harada, Takashi" sort="Harada, Takashi" uniqKey="Harada T" first="Takashi" last="Harada">Takashi Harada</name>
</author>
<author><name sortKey="Greer, Catherine E" sort="Greer, Catherine E" uniqKey="Greer C" first="Catherine E" last="Greer">Catherine E. Greer</name>
</author>
<author><name sortKey="Polo, John M" sort="Polo, John M" uniqKey="Polo J" first="John M" last="Polo">John M. Polo</name>
</author>
<author><name sortKey="Pileri, Piero" sort="Pileri, Piero" uniqKey="Pileri P" first="Piero" last="Pileri">Piero Pileri</name>
</author>
<author><name sortKey="Eickmann, Markus" sort="Eickmann, Markus" uniqKey="Eickmann M" first="Markus" last="Eickmann">Markus Eickmann</name>
</author>
<author><name sortKey="Rappuoli, Rino" sort="Rappuoli, Rino" uniqKey="Rappuoli R" first="Rino" last="Rappuoli">Rino Rappuoli</name>
</author>
<author><name sortKey="Abrignani, Sergio" sort="Abrignani, Sergio" uniqKey="Abrignani S" first="Sergio" last="Abrignani">Sergio Abrignani</name>
</author>
<author><name sortKey="Houghton, Michael" sort="Houghton, Michael" uniqKey="Houghton M" first="Michael" last="Houghton">Michael Houghton</name>
</author>
<author><name sortKey="Han, Jang H" sort="Han, Jang H" uniqKey="Han J" first="Jang H" last="Han">Jang H. Han</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15367599</idno>
<idno type="pmid">15367599</idno>
<idno type="doi">10.1128/JVI.78.19.10328-10335.2004</idno>
<idno type="wicri:Area/PubMed/Corpus">002B54</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B54</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.</title>
<author><name sortKey="Song, Hyun Chul" sort="Song, Hyun Chul" uniqKey="Song H" first="Hyun Chul" last="Song">Hyun Chul Song</name>
<affiliation><nlm:affiliation>Vaccines Research, Chiron Corporation, 4560 Horton St., Emeryville, CA 94608, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Seo, Mi Young" sort="Seo, Mi Young" uniqKey="Seo M" first="Mi-Young" last="Seo">Mi-Young Seo</name>
</author>
<author><name sortKey="Stadler, Konrad" sort="Stadler, Konrad" uniqKey="Stadler K" first="Konrad" last="Stadler">Konrad Stadler</name>
</author>
<author><name sortKey="Yoo, Byoung J" sort="Yoo, Byoung J" uniqKey="Yoo B" first="Byoung J" last="Yoo">Byoung J. Yoo</name>
</author>
<author><name sortKey="Choo, Qui Lim" sort="Choo, Qui Lim" uniqKey="Choo Q" first="Qui-Lim" last="Choo">Qui-Lim Choo</name>
</author>
<author><name sortKey="Coates, Stephen R" sort="Coates, Stephen R" uniqKey="Coates S" first="Stephen R" last="Coates">Stephen R. Coates</name>
</author>
<author><name sortKey="Uematsu, Yasushi" sort="Uematsu, Yasushi" uniqKey="Uematsu Y" first="Yasushi" last="Uematsu">Yasushi Uematsu</name>
</author>
<author><name sortKey="Harada, Takashi" sort="Harada, Takashi" uniqKey="Harada T" first="Takashi" last="Harada">Takashi Harada</name>
</author>
<author><name sortKey="Greer, Catherine E" sort="Greer, Catherine E" uniqKey="Greer C" first="Catherine E" last="Greer">Catherine E. Greer</name>
</author>
<author><name sortKey="Polo, John M" sort="Polo, John M" uniqKey="Polo J" first="John M" last="Polo">John M. Polo</name>
</author>
<author><name sortKey="Pileri, Piero" sort="Pileri, Piero" uniqKey="Pileri P" first="Piero" last="Pileri">Piero Pileri</name>
</author>
<author><name sortKey="Eickmann, Markus" sort="Eickmann, Markus" uniqKey="Eickmann M" first="Markus" last="Eickmann">Markus Eickmann</name>
</author>
<author><name sortKey="Rappuoli, Rino" sort="Rappuoli, Rino" uniqKey="Rappuoli R" first="Rino" last="Rappuoli">Rino Rappuoli</name>
</author>
<author><name sortKey="Abrignani, Sergio" sort="Abrignani, Sergio" uniqKey="Abrignani S" first="Sergio" last="Abrignani">Sergio Abrignani</name>
</author>
<author><name sortKey="Houghton, Michael" sort="Houghton, Michael" uniqKey="Houghton M" first="Michael" last="Houghton">Michael Houghton</name>
</author>
<author><name sortKey="Han, Jang H" sort="Han, Jang H" uniqKey="Han J" first="Jang H" last="Han">Jang H. Han</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antigens, Viral (chemistry)</term>
<term>Antigens, Viral (genetics)</term>
<term>Antigens, Viral (immunology)</term>
<term>Antigens, Viral (metabolism)</term>
<term>COS Cells</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Cricetinae</term>
<term>Culture Media (chemistry)</term>
<term>DNA, Complementary</term>
<term>DNA, Viral (genetics)</term>
<term>DNA, Viral (metabolism)</term>
<term>Endoplasmic Reticulum (chemistry)</term>
<term>Glycoside Hydrolases (metabolism)</term>
<term>Golgi Apparatus (chemistry)</term>
<term>Membrane Glycoproteins (chemistry)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Molecular Weight</term>
<term>Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase (metabolism)</term>
<term>Protein Folding</term>
<term>Protein Processing, Post-Translational</term>
<term>Protein Structure, Tertiary</term>
<term>Protein Subunits (analysis)</term>
<term>Protein Transport</term>
<term>Recombinant Proteins (chemistry)</term>
<term>Recombinant Proteins (genetics)</term>
<term>Recombinant Proteins (immunology)</term>
<term>Recombinant Proteins (metabolism)</term>
<term>SARS Virus (genetics)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (chemistry)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Viral Envelope Proteins (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Protein Subunits</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antigens, Viral</term>
<term>Culture Media</term>
<term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Viral</term>
<term>DNA, Viral</term>
<term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Viral</term>
<term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antigens, Viral</term>
<term>DNA, Viral</term>
<term>Glycoside Hydrolases</term>
<term>Membrane Glycoproteins</term>
<term>Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Endoplasmic Reticulum</term>
<term>Golgi Apparatus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>COS Cells</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Cricetinae</term>
<term>DNA, Complementary</term>
<term>Molecular Weight</term>
<term>Protein Folding</term>
<term>Protein Processing, Post-Translational</term>
<term>Protein Structure, Tertiary</term>
<term>Protein Transport</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We have expressed and characterized the severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein in cDNA-transfected mammalian cells. The full-length spike protein (S) was newly synthesized as an endoglycosidase H (endo H)-sensitive glycoprotein (gp170) that is further modified into an endo H-resistant glycoprotein (gp180) in the Golgi apparatus. No substantial proteolytic cleavage of S was observed, suggesting that S is not processed into head (S1) and stalk (S2) domains as observed for certain other coronaviruses. While the expressed full-length S glycoprotein was exclusively cell associated, a truncation of S by excluding the C-terminal transmembrane and cytoplasmic tail domains resulted in the expression of an endoplasmic reticulum-localized glycoprotein (gp160) as well as a Golgi-specific form (gp170) which was ultimately secreted into the cell culture medium. Chemical cross-linking, thermal denaturation, and size fractionation analyses suggested that the full-length S glycoprotein of SARS-CoV forms a higher order structure of approximately 500 kDa, which is consistent with it being an S homotrimer. The latter was also observed in purified virions. The intracellular form of the C-terminally truncated S protein (but not the secreted form) also forms trimers, but with much less efficiency than full-length S. Deglycosylation of the full-length homotrimer with peptide N-glycosidase-F under native conditions abolished recognition of the protein by virus-neutralizing antisera raised against purified virions, suggesting the importance of the carbohydrate in the correct folding of the S protein. These data should aid in the design of recombinant vaccine antigens to prevent the spread of this emerging pathogen.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15367599</PMID>
<DateCompleted><Year>2004</Year>
<Month>10</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>78</Volume>
<Issue>19</Issue>
<PubDate><Year>2004</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.</ArticleTitle>
<Pagination><MedlinePgn>10328-35</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We have expressed and characterized the severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein in cDNA-transfected mammalian cells. The full-length spike protein (S) was newly synthesized as an endoglycosidase H (endo H)-sensitive glycoprotein (gp170) that is further modified into an endo H-resistant glycoprotein (gp180) in the Golgi apparatus. No substantial proteolytic cleavage of S was observed, suggesting that S is not processed into head (S1) and stalk (S2) domains as observed for certain other coronaviruses. While the expressed full-length S glycoprotein was exclusively cell associated, a truncation of S by excluding the C-terminal transmembrane and cytoplasmic tail domains resulted in the expression of an endoplasmic reticulum-localized glycoprotein (gp160) as well as a Golgi-specific form (gp170) which was ultimately secreted into the cell culture medium. Chemical cross-linking, thermal denaturation, and size fractionation analyses suggested that the full-length S glycoprotein of SARS-CoV forms a higher order structure of approximately 500 kDa, which is consistent with it being an S homotrimer. The latter was also observed in purified virions. The intracellular form of the C-terminally truncated S protein (but not the secreted form) also forms trimers, but with much less efficiency than full-length S. Deglycosylation of the full-length homotrimer with peptide N-glycosidase-F under native conditions abolished recognition of the protein by virus-neutralizing antisera raised against purified virions, suggesting the importance of the carbohydrate in the correct folding of the S protein. These data should aid in the design of recombinant vaccine antigens to prevent the spread of this emerging pathogen.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName>
<ForeName>Hyun Chul</ForeName>
<Initials>HC</Initials>
<AffiliationInfo><Affiliation>Vaccines Research, Chiron Corporation, 4560 Horton St., Emeryville, CA 94608, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Seo</LastName>
<ForeName>Mi-Young</ForeName>
<Initials>MY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Stadler</LastName>
<ForeName>Konrad</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yoo</LastName>
<ForeName>Byoung J</ForeName>
<Initials>BJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Choo</LastName>
<ForeName>Qui-Lim</ForeName>
<Initials>QL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Coates</LastName>
<ForeName>Stephen R</ForeName>
<Initials>SR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Uematsu</LastName>
<ForeName>Yasushi</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Harada</LastName>
<ForeName>Takashi</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Greer</LastName>
<ForeName>Catherine E</ForeName>
<Initials>CE</Initials>
</Author>
<Author ValidYN="Y"><LastName>Polo</LastName>
<ForeName>John M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pileri</LastName>
<ForeName>Piero</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Eickmann</LastName>
<ForeName>Markus</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rappuoli</LastName>
<ForeName>Rino</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Abrignani</LastName>
<ForeName>Sergio</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Houghton</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Han</LastName>
<ForeName>Jang H</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003470">Culture Media</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D021122">Protein Subunits</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.2.1.-</RegistryNumber>
<NameOfSubstance UI="D006026">Glycoside Hydrolases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.5.1.52</RegistryNumber>
<NameOfSubstance UI="D043524">Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003470" MajorTopicYN="N">Culture Media</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006026" MajorTopicYN="N">Glycoside Hydrolases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006056" MajorTopicYN="N">Golgi Apparatus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D043524" MajorTopicYN="N">Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021122" MajorTopicYN="N">Protein Subunits</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>9</Month>
<Day>16</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>9</Month>
<Day>16</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15367599</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.78.19.10328-10335.2004</ArticleId>
<ArticleId IdType="pii">78/19/10328</ArticleId>
<ArticleId IdType="pmc">PMC516425</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Virology. 2000 Mar 30;269(1):212-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10725213</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1999 Oct;73(10):8152-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10482565</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1351</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12775803</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Aug;77(16):8801-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12885899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Oct;77(19):10394-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12970424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Oct;77(20):11244-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14512572</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Oct 30;425(6961):915</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14586458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14651994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 Nov 28;302(5650):1504-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645828</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Avian Pathol. 2003 Dec;32(6):567-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14676007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Microbiol. 2003 Sep 21;3:20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14499001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Mar 5;315(2):439-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14766227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1977 Jun 15;79(2):446-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">867833</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1981 Jan 29;289(5796):366-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7464906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1986 Sep 12;46(6):929-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3019557</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1986 Sep 12;46(6):939-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3757030</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 1986 Oct;103(4):1179-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2429970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1986 Dec;60(3):833-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3783818</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cell Biol. 1987 Nov;105(5):1957-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2824524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1988 Mar 25;52(6):843-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2450677</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1990 Nov;64(11):5367-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2170676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1991 Jun;182(2):765-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1850927</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1993 Nov;67(11):6753-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8411378</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1998 Jun 18;393(6686):705-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9641684</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4598-603</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10200308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Dec;76(24):12491-502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12438575</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B54 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002B54 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:15367599 |texte= Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15367599" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |